ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
Transgene Biotek has received ROC approval to extend its 36th AGM deadline by three months. The meeting for FY2025-26 will now be held by December 31, 2026.
Transgene Biotek Ltd announced the resignation of M/s Vasavi & Co. as Statutory Auditors, effective immediately. The auditors cited pre-occupation with other assignments as the reason.
Transgene Biotek submitted its quarterly shareholding pattern for the period ending December 2016. The company noted that certain promoter shares remain in physical form pending listing approval.
Transgene Biotek Limited has appointed M/s Manisha Dubey & Associates as Internal Auditors for a 12-month term. The board approved the appointment during its August 7, 2026 meeting.
Transgene Biotek Ltd reported revenue from operations of ₹0.1 Cr and a net loss of ₹0.4 Cr for Q1 FY27.
Transgene Biotek Limited scheduled a board meeting for August 07, 2026, to consider quarterly financial results and AGM extension.
Transgene Biotek allotted 1,00,00,000 equity shares worth Rs.10 Crore to its promoter on a preferential basis. The allotment converts existing unsecured promoter loans into equity.